Literature DB >> 21323945

Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics.

Jason C Carvalho1, Matthew J Wasco, Lakshmi P Kunju, Dafydd G Thomas, Rajal B Shah.   

Abstract

AIMS: To develop an immunohistochemical strategy for distinguishing renal oncocytoma (RO) from the eosinophilic variant of chromophobe (ChRCC), and papillary (PRCC) and clear cell (CRCC) renal cell carcinoma containing eosinophilic cytoplasm in core biopsy specimens. METHODS AND
RESULTS: Cluster analysis was performed on immunohistochemical data from 21 RO, 16 ChRCC, 16 CRCC and 20 PRCC patients. A panel of CK7, C-kit, S100A1 and vimentin clustered into four groups. Cluster A (94% ChRCC) expressed C-kit and CK7 and lacked S100A1 and vimentin. Cluster B (95% RO) expressed C-kit, S100A1, focal CK7 (single or small clusters of cells) and lacked vimentin. Cluster C comprised a mixture of PRCC and CRCC with no expression of C-kit or CK7 and variable S100A1 and vimentin. PRCC with strong expression of CK7 clustered into group D. A panel of S100A1 (positive) and focal CK7 expression distinguished RO from ChRCC with 91% sensitivity and 93% specificity. A panel of vimentin (negative) and C-kit (positive) distinguished RO from CRCC with 83% sensitivity and 86% specificity and RO from PRCC with 79% sensitivity and 88% specificity.
CONCLUSIONS: Hierarchical cluster analysis is an effective approach to analyse high-volume immunohistochemical data to generate an optimal panel in the differential diagnosis of oncocytoma from its mimics.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323945     DOI: 10.1111/j.1365-2559.2011.03753.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  14 in total

1.  Renal tumors: diagnostic and prognostic biomarkers.

Authors:  Puay Hoon Tan; Liang Cheng; Nathalie Rioux-Leclercq; Maria J Merino; George Netto; Victor E Reuter; Steven S Shen; David J Grignon; Rodolfo Montironi; Lars Egevad; John R Srigley; Brett Delahunt; Holger Moch
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

Review 2.  Diagnostic approach to eosinophilic renal neoplasms.

Authors:  Oleksandr N Kryvenko; Merce Jorda; Pedram Argani; Jonathan I Epstein
Journal:  Arch Pathol Lab Med       Date:  2014-11       Impact factor: 5.534

3.  LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.

Authors:  Gang Zheng; Alcides Chaux; Rajni Sharma; George Netto; Patrizio Caturegli
Journal:  Exp Mol Pathol       Date:  2012-06-12       Impact factor: 3.362

Review 4.  Interpretation of needle biopsies of the kidney for investigation of renal masses.

Authors:  Benoît Lhermitte; Laurence de Leval
Journal:  Virchows Arch       Date:  2012-06-08       Impact factor: 4.064

5.  HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.

Authors:  Jiyeon An; Cheol Keun Park; Moonsik Kim; Jin Woo Joo; Nam Hoon Cho
Journal:  Virchows Arch       Date:  2020-08-20       Impact factor: 4.064

6.  Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.

Authors:  Sarika Jain; Somak Roy; Milon Amin; Marie Acquafondata; Ming Yin; William Laframboise; Sheldon Bastacky; Liron Pantanowitz; Rajiv Dhir; Anil Parwani
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

7.  Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC).

Authors:  Francisco Javier Queipo Gutiérrez; Ángel Panizo; Antonio Tienza; Irene Rodriguez; Jesús Javier Sola; Jordi Temprana-Salvador; Inés de Torres; Javier Pardo-Mindán
Journal:  Virchows Arch       Date:  2018-06-21       Impact factor: 4.064

8.  Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

Authors:  Keng Lim Ng; Robert J Ellis; Hemamali Samaratunga; Christudas Morais; Glenda C Gobe; Simon T Wood
Journal:  Transl Androl Urol       Date:  2019-05

Review 9.  Modern Pathologic Diagnosis of Renal Oncocytoma.

Authors:  Sara E Wobker; Sean R Williamson
Journal:  J Kidney Cancer VHL       Date:  2017-10-09

10.  Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma.

Authors:  Qingping Guo; Jiale Wang; Zeyu Cao; Yongchang Tang; Chao Feng; Feizhou Huang
Journal:  Int J Oncol       Date:  2018-06-05       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.